Search Results - "Ringler, Anna"
-
1
Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYH
Published in Molecular cell (16-11-2017)“…DNA lesions caused by UV damage are thought to be repaired solely by the nucleotide excision repair (NER) pathway in human cells. Patients carrying mutations…”
Get full text
Journal Article -
2
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor
Published in Nature chemical biology (01-07-2017)“…The use of a refined chemical library called the CeMM library of unique drugs (CLOUD) identified a synergistic interaction between flutamide and phenprocoumon…”
Get full text
Journal Article -
3
Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers
Published in Nature genetics (01-09-2019)“…Aberrations in genes coding for subunits of the BRG1/BRM associated factor (BAF) chromatin remodeling complexes are highly abundant in human cancers…”
Get full text
Journal Article -
4
MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation
Published in Nature genetics (01-06-2019)“…The histone acetyl reader bromodomain-containing protein 4 (BRD4) is an important regulator of chromatin structure and transcription, yet factors modulating…”
Get full text
Journal Article -
5
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
Published in Cancer cell (14-01-2019)“…The marsupial Tasmanian devil (Sarcophilus harrisii) faces extinction due to transmissible devil facial tumor disease (DFTD). To unveil the molecular…”
Get full text
Journal Article -
6
Global survey of the immunomodulatory potential of common drugs
Published in Nature chemical biology (01-06-2017)“…A high-content screening platform that measures the immunological potential of small-molecule and biologic drugs by computationally determining changes in the…”
Get full text
Journal Article -
7
CDK6 Antagonizes p53-Induced Responses during Tumorigenesis
Published in Cancer discovery (01-07-2018)“…Tumor formation is a multistep process during which cells acquire genetic and epigenetic changes until they reach a fully transformed state. We show that CDK6…”
Get more information
Journal Article -
8
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
Published in Nature chemical biology (01-03-2019)“…The Bruton tyrosine kinase (BTK) inhibitor ibrutinib has substantially improved therapeutic options for chronic lymphocytic leukemia (CLL). Although ibrutinib…”
Get full text
Journal Article -
9
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
Published in The Lancet. Haematology (01-12-2017)“…Patients with refractory or relapsed haematological malignancies have few treatment options and short survival times. Identification of effective therapies…”
Get full text
Journal Article -
10
5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines
Published in Archiv der Pharmazie (Weinheim) (01-04-2021)“…The data on the pharmacology of 4‐thiazolidinones showed that 5‐ene‐2‐(imino)amino‐4‐thiazolidinones are likely to comprise one of the most promising groups of…”
Get full text
Journal Article -
11
Systematic characterization of BAF mutations provides insights into intra-complex synthetic lethalities in human cancers
Published in Nature genetics (19-08-2019)“…Aberrations in genes coding for subunits of the BAF chromatin remodeling complexes are highly abundant in human cancers. Currently, it is not understood how…”
Get full text
Journal Article -
12
Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients
Published in Blood (08-12-2017)“…▪ Chronic lymphocytic leukemia (CLL) is characterized by clonal proliferation and accumulation of malignant B lymphocytes in the blood, bone marrow, spleen,…”
Get full text
Journal Article -
13
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
Published in Oncotarget (04-04-2017)“…In chronic myeloid leukemia (CML) resistance against one or more BCR-ABL1 tyrosine kinase inhibitors (TKI) remains a clinical challenge. Preclinical data…”
Get full text
Journal Article -
14
Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies
Published in Blood (08-12-2017)“…Background. Patients with aggressive hematologic malignancies failing at least two lines of therapy are without further standard treatment options and have a…”
Get full text
Journal Article